Age is the largest risk factor for developing symptoms of dementia. With the combination of this risk factor and the largest generation reaching the age of retirement, it is becoming increasingly important that healthcare providers are able to field questions and concerns about the heritability of various causes of dementia. Identifying and confirming a molecular diagnosis for conditions such as Alzheimer disease and frontotemporal dementia can lead to access to clinical trials and provide information for family members who are at risk for these conditions.
During this educational webinar, Kaylee Faulkner, MS, CGC, will review common causes of dementia and discuss the heritability of these conditions as well as the testing considerations clinicians may have when ordering genetic testing.
- Review causes of dementia and the common genetic factors that increase one’s risk of developing these conditions
- Provide clinical insight for the utility of genetic testing for those with a diagnosis of Alzheimer disease or frontotemporal dementia
- Describe genetic testing options and considerations when ordering testing
Kaylee Faulkner, MS, CGC received a Bachelor of Science in Biology from Loyola University in Chicago and a Masters of Science with honors in Genetic Counseling from Arcadia University in Glenside, Pennsylvania, USA. She specialized as a genetic counselor in clinical adult neurogenetics at the University of Iowa and most recently at the Hospital of the University of Pennsylvania with a focus in frontotemporal dementia and Amyotrophic Lateral Sclerosis. After transitioning to an industry role, she joined Blueprint Genetics in January 2020 as a Genetic Services Consultant based out of Chicago. She works closely with clinicians across the Midwest. With her specialization in neuroedegenerative disease, Kaylee has served as the team’s clinical and adult neurogenetics consultant.